MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C

OBJECT: Non-small lung cancer (NSCLC), with a poor 5-year survival rate (16%), is the major type of lung cancer. Metastasis has been identified as the main factor that leads to NSCLC therapy failure. MiR-206 is a metastasis suppressor in many cancers, including colorectal cancer, renal cell carcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Ming, Peng, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079403/
https://www.ncbi.nlm.nih.gov/pubmed/32206066
http://dx.doi.org/10.1186/s11658-020-00216-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079403/
https://www.ncbi.nlm.nih.gov/pubmed/32206066
http://dx.doi.org/10.1186/s11658-020-00216-x

Ejemplares similares